Showing results (371-380 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|October 13, 2009
Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare SystemM Fuller, K Shermock, P Russo, et al.Journal of Medical Economics|January 19, 2021
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progressionLaurie J Brown, Jinjing Li, Matthias Brunner, et al.Journal of Medical Economics|January 19, 2021
Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in AustraliaNikolaos Kotsopoulos, Mark P Connolly, Jinjing LiJournal of Medical Economics|January 20, 2021
Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysisNaoki Hosogaya, Takahiro Takazono, Akira Yokomasu, et al.Journal of Medical Economics|January 20, 2021
Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA studyLucas Higuera, Reece Holbrook, Kael Wherry, et al.Journal of Medical Economics|September 7, 2019
Outcomes of transcatheter aortic valve implantation for intermediate-risk patients in Australia: the SOLACE-AU trialPeter Lee, Josh Byrnes, Merehau Mervin, et al.Journal of Medical Economics|September 14, 2019
Total costs of treating venous thromboembolism: implication of different cost perspectives in a Danish settingAgnete Nielsen, Peter Bo Poulsen, Lars Dybro, et al.Journal of Medical Economics|February 4, 2021
Burden of caring for Alzheimer's disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional surveyShinya Ohno, Yirong Chen, Hiroyuki Sakamaki, et al.Journal of Medical Economics|February 16, 2021
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic modelNanxin Li, Eileen K Sawyer, Konrad Maruszczyk, et al.Journal of Medical Economics|February 26, 2021
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularizationUrvi Desai, Akshay Kharat, Connie N Hess, et al.Pageof 241